Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,701.30
+167.40 (10.91%)
At close: Dec 9, 2025
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 231.75 billion as of December 9, 2025. Its market cap has increased by 24.57% in one year.
Market Cap
231.75B
Enterprise Value
259.01B
Revenue
29.86B
Ranking
n/a
PE Ratio
55.86
Stock Price
1,701.30
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 231.75B, an increase of 180.20%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 231.75B | 23.93% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | 78.75B | 20.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.31T |
| Divi's Laboratories | 1.67T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 925.99B |
| Mankind Pharma | 902.08B |
| Aurobindo Pharma | 683.84B |
| Alkem Laboratories | 677.63B |